NCT07586527

Brief Summary

The purpose of this randomized controlled trial is to evaluate the effectiveness of an 8-week interoception-integrated adapted mindfulness training program for patients with type 1 or type 2 diabetes who experience impaired awareness of hypoglycemia (IAH). The study aims to determine whether this mindfulness intervention, which includes techniques such as body scanning and mindful eating, can help patients better recognize early physiological signals of low blood sugar compared to routine care. Researchers will measure changes in participants' interoceptive awareness and the severity of their IAH over a 3-month follow-up period. The ultimate goal is to provide a practical psychological approach to improve symptom perception and reduce the risk of severe hypoglycemic events in diabetic patients.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
10mo left

Started Jun 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Jun 2026Jun 2027

First Submitted

Initial submission to the registry

May 8, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 14, 2026

Completed
18 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

May 14, 2026

Status Verified

May 1, 2026

Enrollment Period

1 year

First QC Date

May 8, 2026

Last Update Submit

May 8, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Clark Score

    Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention

  • Gold Score

    Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention

  • Multidimensional Assessment of Interoceptive Awareness Version 2

    Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention

Secondary Outcomes (2)

  • Five Facet Mindfulness

    Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention

  • Negative Cognitive Processing Bias Questionnaire

    Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participants receive an 8-week interoception-integrated adapted mindfulness training program, in addition to routine treatment, examinations, nursing care, and health education.

Behavioral: Adapted Mindfulness Training

Control Group

ACTIVE COMPARATOR

Participants receive routine treatment, examinations, nursing care, and health education only, without the mindfulness training during the 8-week study period.

Behavioral: Routine Intervention

Interventions

An 8-week adapted mindfulness program, based on Mindfulness-Based Stress Reduction (MBSR), is delivered to patients with Impaired Awareness of Hypoglycemia (IAH) by a multidisciplinary team. It involves weekly 1-1.5 hour face-to-face group sessions (8-10 participants) and daily home practices supervised via a WeChat group. Tailored to IAH, the curriculum integrates core skills (mindful meditation, yoga, breathing, and walking) with IAH-specific elements. By training self-awareness, attentional control, and emotional regulation, it aims to enhance interoceptive awareness. This strengthens hypoglycemia-related perceptual behaviors, helping patients acquire self-regulation skills, attend to physical sensations of hypoglycemia, perceive nocturnal hypoglycemia, and identify fear of hypoglycemia.

Intervention Group

The control group receives routine medical care, examinations, nursing, and health education. While they undergo the same follow-up schedule as the intervention group, no mindfulness practice guidance is provided during the study period. Upon the conclusion of the study, mindfulness-related materials will be distributed to these participants.

Control Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with type 1 or type 2 diabetes mellitus according to the latest American Diabetes Association (ADA) Standards of Care in Diabetes;
  • Receiving insulin therapy for ≥ 1 year;
  • Age between 18 and 80 years (inclusive);
  • Duration of diabetes ≥ 5 years;
  • Gold score ≥ 4 and Clarke score ≥ 4;
  • Voluntary participation and provision of signed informed consent.

You may not qualify if:

  • Prior experience with mindfulness interventions;
  • Diagnosed with cognitive impairment, psychiatric disorders, or other severe physical comorbidities;
  • Current use of psychotropic medications;
  • Pregnant or lactating women, or women of childbearing potential not using effective contraception.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Graduate Student

Study Record Dates

First Submitted

May 8, 2026

First Posted

May 14, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

May 14, 2026

Record last verified: 2026-05